CION Ameerpet
Pancreatic Cancer · Diagnosis & Tests · Reviewed by CION Oncologists
Blood and liver function tests — what they show in pancreatic cancer
No blood test can diagnose pancreatic cancer, and none can rule it out. What a liver panel can do is show whether the bile duct is blocked, how the rest of the body is coping, and give a baseline that every later result is measured against — a different job, and a more useful one.
- No blood test diagnoses it — a normal panel is not an all-clear, and an abnormal one is not a verdict.
- Bilirubin is the one to watch — painless yellowing with a rising bilirubin needs checking the same week.
- The trend beats the reading — direction across successive tests says far more than one value on one day.
- A blocked duct distorts the marker — CA 19-9 rises with obstruction alone, so when it is taken matters.
17+
Cancer Specialists
on Panel
on Panel
35+
Centres Across
Telangana & AP
Telangana & AP
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Start here
What Blood Tests Can and Cannot Say
People look up pancreatic cancer blood tests for one of two reasons. Either a routine panel has come back abnormal and nobody has explained it properly, or a diagnosis has just been made and a long list of tests has appeared on a form. Whichever brought you here, the honest starting point is the uncomfortable one: there is no blood test that diagnoses pancreatic cancer, and no blood test that rules it out. No single line on a report can do either job.
What bloods do instead is three quieter things, and each of them matters more than people expect. They show whether the bile duct is blocked, and how badly. They show how the rest of the body is coping — the liver, the kidneys, the blood count, the clotting, the nutritional state. And they lay down a baseline, so the next set of results can be read against this one rather than judged in isolation.
The panel most people are handed is the liver function test, often printed simply as LFT. It is not a test of the pancreas at all. It measures how the liver and the bile drainage system are behaving — which matters here because the head of the pancreas sits directly against the lower end of the bile duct. A tumour in that position presses on the duct, bile backs up, and the liver panel shifts before almost anything else does. That is why a liver test is so often the first clue to a pancreatic problem, and why the phrase people go on to search is liver function pancreatic cancer.
The rest of this page goes through a report line by line: what each value is measuring, what a raised result points at, and where the bloods stop and imaging has to take over. For the wider picture — symptoms, diagnosis, staging and treatment — start from our complete guide to pancreatic cancer. This page stays with the blood report.
Did you know? NCCN guidance treats CA 19-9 as a test with a precondition attached. It is meant to be interpreted only once a blocked bile duct has been drained and the bilirubin has settled, because obstruction raises the marker on its own — a jaundiced reading can look alarming for reasons that have nothing to do with how much cancer is present. The same guidance frames the marker as a baseline and a trend in people with a confirmed diagnosis, not as a screening or diagnostic test in anyone else. There is a second quirk worth knowing: a minority of people do not carry the Lewis blood-group antigen and never produce CA 19-9 at all, so their result stays low whatever is happening inside them. Those two facts together are why a single marker value is almost never acted on alone.
Line by line
What Each Result Is Actually Telling You
Reports are printed for other doctors, which is why they read as a wall of abbreviations. Here is what the recurring ones are pointing at. None of them, alone, says cancer.
Bilirubin
The pigment that turns you yellow
Bilirubin rises when bile cannot drain. Gallstones, hepatitis and medication all raise it too. What makes doctors look hard at the pancreas is bilirubin climbing steadily with no pain and no fever — the pattern explained in painless jaundice and what it means.
ALP and GGT
The obstruction pair
Alkaline phosphatase and gamma-GT come from the lining of the bile ducts. When they rise together, and rise further than the liver-cell enzymes, the pattern points at a drainage problem rather than at the liver itself.
ALT and AST
The liver-cell enzymes
These leak out when liver cells are irritated. A modest rise is common in obstruction. A very large rise with normal drainage enzymes usually points somewhere else entirely, such as a viral or medication-related cause.
Albumin
A quiet marker of nutrition
Albumin drifts down with poor intake, malabsorption and chronic illness. It is one of the few values on the panel that tracks how well someone is actually eating and absorbing, which is why the dietitian reads it as closely as the oncologist does.
PT and INR
Clotting, checked before anything sharp
Bile is needed to absorb vitamin K, and vitamin K is needed to clot. Prolonged obstruction stretches the clotting time. It is checked before any biopsy, stent or operation, and it usually corrects once drainage is restored.
Full blood count
Haemoglobin, white cells, platelets
Anaemia can point at slow blood loss where a tumour has reached the duodenum. A high white cell count raises the question of infected, obstructed bile. Platelets matter before any procedure is booked.
Glucose and HbA1c
Blood sugar, and new diabetes
Diabetes appearing for the first time in later life, especially alongside weight loss, deserves a proper assessment rather than a repeat prescription. This pattern is sometimes called type 3c diabetes. New diabetes does not mean cancer — it means the question is worth asking.
Kidney function
Checked before the contrast goes in
Creatinine and electrolytes are usually taken before a contrast scan, and again before chemotherapy. Vomiting and poor intake shift them quickly, so an abnormal result is often about hydration rather than about the kidneys.
CA 19-9
A trend to follow, not a diagnosis
The tumour marker is the one people fixate on, and the one most often misread. It can be pushed up by a blocked duct alone and can sit normal in real disease. What it is genuinely good for is set out in the CA 19-9 tumour marker explained.
The report in your hand
Reading a Blood Report Without Panicking
Most abnormal liver panels are not cancer. Here is how a specialist actually reads the page, and which single finding genuinely changes the timetable.
- One value out of range is not a diagnosis. Laboratory ranges are set so that a share of perfectly well people fall outside them. A slightly high enzyme on an otherwise ordinary panel, in someone with no symptoms, is one of the most common findings in medicine and is very rarely sinister.
- The pattern matters more than any single line. Bilirubin, alkaline phosphatase and gamma-GT rising together, with the liver-cell enzymes only mildly up, describes obstruction. The reverse pattern describes liver inflammation. The two lead down completely different paths.
- Direction beats magnitude. A value that has climbed across successive tests says far more than one high reading on one day. This is why doctors ask for old reports, and why repeating a test is not a delaying tactic.
- Painless yellowing is the one that cannot wait. Yellow eyes or skin, dark urine and pale stools without pain or fever should be assessed the same week, not at the next convenient appointment. Why that specific combination carries such weight is explained in the painless jaundice warning sign.
- A normal liver panel does not exclude a pancreatic tumour. Tumours in the body and tail of the gland sit far from the bile duct and can grow for a long time without disturbing a single liver value. Persistent upper abdominal or back pain and unexplained weight loss still deserve imaging, whatever the bloods say.
- CA 19-9 is often deliberately left off the first panel. Ordering it in a well person with vague symptoms tends to generate alarm and unnecessary scans rather than answers. Its proper place is after a diagnosis, and after any blockage has been drained.
- Bring the older reports, not only the newest one. A single printout can be read; a run of printouts can be interpreted. If you have results from a previous year sitting in a folder, they are worth digging out before your appointment.
What we will not do: treat one raised value as a verdict, or send you for tests before anyone has explained why. Book a free consultation or call 1800 202 8726.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
A Report Lists Values. Someone Should Tell You What They Mean.
Bloods, liver function and CA 19-9 are ordered, drawn and reported by CION across 35+ centres.
What actually happens
What Happens When You Bring Blood Reports to CION
-
A free 45-minute consultation, with the reports open
The first appointment is long enough to go through the printout with you, value by value, and to say plainly which lines are meaningful and which are noise. Bring every report you have, including older ones, and your medication list.
In-house at CION -
The bloods themselves, drawn and reported here
Liver function, bilirubin, clotting, full blood count, kidney function, blood sugar and, where it is appropriate, the CA 19-9 marker are ordered, drawn and reported through CION across 35+ centres. You will be told why each one is on the form before it is taken.
In-house at CION -
An honest answer on what needs repeating
Plenty of outside bloods are perfectly usable and get used as they are. Some are too old to describe the situation now, and some were taken while a duct was still blocked, which distorts the marker. We will say which of those applies rather than quietly reordering everything.
In-house at CION -
If jaundice is the problem, drainage comes first
When bilirubin is high and climbing, relieving the blockage takes priority over almost everything else. ERCP with a biliary stent, and endoscopic ultrasound with a needle biopsy where tissue is needed, are arranged with specialist gastroenterology and endoscopy partner centres and may be billed there.
Coordinated with specialist partner centres -
Then a plan, built on the bloods and the scan together
Chemotherapy, radiation, chemoradiation and SBRT, genetic counselling, nutrition and pancreatic enzyme support, pain and psycho-oncology care are delivered by CION. Any pancreatic operation, along with endoscopic stenting and staging laparoscopy, is coordinated with partner centres. The whole pathway is set out in pancreatic cancer treatment in Hyderabad.
In-house planning, coordinated procedures
If you are holding a report nobody has walked you through, that is reason enough to come in. Book a free consultation or call 1800 202 8726.
The uncomfortable bit, said plainly
Why a Normal Blood Panel Is Not an All-Clear
Blood tests measure the consequences of a problem, not the problem itself. A tumour has to do something — block a duct, bleed, interfere with eating, disturb sugar control — before it registers on a panel at all. A small tumour that has not yet done any of those things leaves the bloods looking entirely ordinary. That is the most important limitation to hold on to, and it is the reason nobody should use a blood test as a general reassurance check.
The reverse is true too, and it causes far more distress than it should. Abnormal liver values are extremely common, and they are usually caused by something benign: gallstones, fatty liver, alcohol, a recent viral illness, or a medicine that irritates the liver. Being sent for a scan after an abnormal panel is a doctor being thorough about a question, not a doctor telling you something without saying it. Most of those scans come back with an explanation that has nothing to do with cancer.
The marker sits in the same territory. CA 19-9 can be pushed up by a blocked duct, by inflammation of the pancreas or the bile ducts, and by other conditions entirely; it can also sit stubbornly normal in someone with confirmed disease, and in people who lack the Lewis antigen it never rises at all. Used as a trend in someone already diagnosed, after any blockage has been drained, it earns its place on the form. Used as a screening test in a well person, it mostly generates fear.
So the practical version is short. Bloods tell you how the drainage and the body are doing, and they set the baseline everything later is compared against. Imaging tells you whether there is a mass and where it sits. Tissue tells you what the cells are. All three answer different questions, and only together do they make a diagnosis. If your bloods are normal but your symptoms are persisting, that is a reason to go back and ask for the next test, not a reason to stop asking. If they are abnormal, ask what pattern the doctor is seeing and what it is being compared against. Both are fair questions, and you are entitled to a plain answer to each.
Take the next step
Ask What Pattern the Doctor Is Seeing
One value out of range rarely decides anything. The pattern and the direction do. We will go through both with you, and we walk this journey with you.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Blood tests in pancreatic cancer — your questions answered
Which blood tests are done when pancreatic cancer is suspected?
The core set is a liver function panel, which includes bilirubin, alkaline phosphatase, gamma-GT and the liver-cell enzymes, together with a full blood count, kidney function and electrolytes, blood sugar, and a clotting study. Albumin is looked at as a marker of nutrition. The tumour marker CA 19-9 may be added once a diagnosis is being taken seriously, but it is often deliberately left until any blocked bile duct has been drained, because obstruction raises it on its own. None of these tests diagnoses pancreatic cancer. They describe whether bile is draining, how the body is coping, whether it is safe to proceed to a biopsy or a procedure, and what the starting point looks like for everything measured afterwards.
What does a raised bilirubin actually mean?
It means bile is not draining freely from the liver into the intestine. There are many ordinary reasons for that, and gallstones are by far the most common. Hepatitis, alcohol and certain medicines can raise it too. What makes a doctor look carefully at the pancreas is a particular combination: bilirubin climbing steadily, the drainage enzymes rising with it, and no pain and no fever alongside. Painless yellowing of the eyes or skin, with dark urine and pale stools, should be assessed within the same week rather than watched. That is not because it usually turns out to be cancer, because most often it does not, but because when it is something serious, delay is what costs people options.
Is there a blood test that can find pancreatic cancer early?
Not at present, and it is worth being direct about that. There is no blood test in routine practice that reliably detects pancreatic cancer before it causes symptoms, and no country runs a population screening programme for it using blood. CA 19-9 is the marker people ask about, and it is not fit for that purpose: it can be raised by a blocked bile duct or by inflammation in someone with no cancer at all, and it can stay entirely normal in someone who does have it. A small group of people with a strong inherited risk are offered structured surveillance, but that is built around imaging and specialist genetic assessment rather than around a blood test, and it is arranged through a dedicated service.
Why does my CA 19-9 need repeating after a stent was placed?
Because the first reading was measuring two things at once. A blocked bile duct raises CA 19-9 by itself, quite apart from any tumour, so a value taken while you were jaundiced reflects the blockage as much as the disease. Once a stent has been placed and the bilirubin has come down, a repeat reading describes the disease far more honestly, and NCCN guidance is explicit about interpreting the marker in that order. That second value becomes the real baseline. From then on it is the direction of travel across successive tests, alongside your scans and how you actually feel, that carries the meaning, not any single figure on any single day.
My liver tests are abnormal but my scan looked normal. What happens now?
This is a common and usually reassuring combination. Abnormal liver values have many benign causes, and a clear scan removes the most worrying explanations. What usually follows is a look at the pattern of the abnormality, a review of your medicines and alcohol intake, tests for viral hepatitis and other liver conditions, and a repeat panel after an interval to see which way the values are moving. If they settle, that is the answer. If they keep climbing, or if jaundice, weight loss or persistent upper abdominal or back pain appear, the right response is to go back and ask for the next test rather than to rely on the earlier scan. A scan answers the question that was asked on the day it was done.
What does CION do about blood tests, and what happens at the first visit?
The first appointment is a free 45-minute consultation with a medical oncologist, and it is long enough to go through your reports line by line rather than glance at them. Bring every printout you have, including older ones, plus your medication list and any scans. Liver function, bilirubin, clotting, blood count, kidney function, blood sugar and CA 19-9 are ordered, drawn and reported in-house at CION across 35+ centres, as are pancreatic-protocol CT and MRI with MRCP. Where a blocked duct needs draining, or a tissue sample is needed, ERCP with stenting and endoscopic ultrasound with biopsy are coordinated with specialist gastroenterology and endoscopy partner centres and may be billed there, as is any pancreatic surgery. Call 1800 202 8726 or use the form on this page.
Medical disclaimer: This page explains what blood and liver function tests measure in pancreatic cancer and how the results are interpreted, and is reviewed by a CION medical oncologist with reference to NCCN guidance on pancreatic adenocarcinoma. It is general information and not an interpretation of your own results; your report must be read alongside your history, examination, imaging and previous results by a doctor who knows your case. Liver function tests, bilirubin, clotting studies, full blood count, kidney function, blood sugar and CA 19-9, together with pancreatic-protocol CT and MRI with MRCP, multidisciplinary treatment planning, chemotherapy, radiation, chemoradiation and SBRT, genetic counselling, nutrition and pancreatic enzyme (PERT) support, pain, psycho-oncology and survivorship care, are delivered by CION. Endoscopic ultrasound and EUS-FNA biopsy, ERCP and biliary or duodenal stenting, staging laparoscopy, coeliac plexus block, PET-CT and DOTATATE PET, peptide receptor radionuclide therapy, and all pancreatic surgery are coordinated with specialist hepatobiliary, gastroenterology, endoscopy and nuclear medicine partner centres and may be billed there.